Award recordCONTRACT

SOFIE CO.

PIID VA26113C0017· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2013· $655,303 net obligations· UEI JV1AHJHGUGG3· VA

Description

RADIOPHARMACEUTICALS- OPTION YEAR

Base award description: RADIOPHARMACEUTICAL

First action · last action
2012-11-01 · 2018-03-19
Transactions
13
First transaction's obligation
$99,900
Base + all options value (sum of deltas)
$933,998
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 13 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$655,303$0Base award · 2012-11-01 · this action $99,900 · running total $99,900Modification P00002 · 2013-09-17 · this action $22,005 · running total $121,905Modification P00001 · 2013-10-01 · this action $99,900 · running total $221,805Modification P00003 · 2014-02-06 · this action -$1,322 · running total $220,483Modification P00004 · 2014-09-12 · this action $20,000 · running total $240,483Modification P00005 · 2014-10-01 · this action $99,900 · running total $340,383Modification P00007 · 2015-10-01 · this action $99,900 · running total $440,283Modification P00006 · 2015-11-24 · this action $27,000 · running total $467,283Modification P00008 · 2016-03-09 · this action -$2,510 · running total $464,773Modification P00009 · 2016-05-23 · this action $35,045 · running total $499,818Modification P00010 · 2016-10-01 · this action $99,900 · running total $599,718Modification P00011 · 2017-05-17 · this action $43,875 · running total $643,593Modification P00012 · 2018-03-19 · this action $11,710 · running total $655,303
  • Base2012-11-01+$99,900= $99,900
  • Mod P000022013-09-17+$22,005= $121,905
  • Mod P000012013-10-01+$99,900= $221,805
  • Mod P000032014-02-06-$1,322= $220,483
  • Mod P000042014-09-12+$20,000= $240,483
  • Mod P000052014-10-01+$99,900= $340,383
  • Mod P000072015-10-01+$99,900= $440,283
  • Mod P000062015-11-24+$27,000= $467,283
  • Mod P000082016-03-09-$2,510= $464,773
  • Mod P000092016-05-23+$35,045= $499,818
  • Mod P000102016-10-01+$99,900= $599,718
  • Mod P000112017-05-17+$43,875= $643,593
  • Mod P000122018-03-19+$11,710= $655,303
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2012-11-01+$99,900$99,900RADIOPHARMACEUTICAL
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2013-09-17+$22,005$121,905RADIOPHARMACEUTICAL
Mod P00001· EXERCISE AN OPTION2013-10-01+$99,900$221,805RADIOPHARMACEUTICAL
Mod P00003· EXERCISE AN OPTION2014-02-06−$1,322$220,483RADIOPHARMACEUTICALS
Mod P00004· FUNDING ONLY ACTION2014-09-12+$20,000$240,483RADIOPHARMACEUTICALS
Mod P00005· EXERCISE AN OPTION2014-10-01+$99,900$340,383RADIOPHARMACEUTICALS
Mod P00007· EXERCISE AN OPTION2015-10-01+$99,900$440,283RADIOPHARMACEUTICALS
Mod P00006· FUNDING ONLY ACTION2015-11-24+$27,000$467,283RADIOPHARMACEUTICALS ESTIMATED QUANTITY CONTRACT. ADDITIONAL FUNDING ADDED TO PAY FINAL FY 15 INVOICES.
Mod P00008· FUNDING ONLY ACTION2016-03-09−$2,510$464,773RADIOPHARMACEUTICALS- DECREASE FUNDING FOR CONTRACT CLOSEOUT.
Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2016-05-23+$35,045$499,818RADIOPHARMACEUTICALS- DECREASE FUNDING FOR CONTRACT CLOSEOUT.
Mod P00010· EXERCISE AN OPTION2016-10-01+$99,900$599,718RADIOPHARMACEUTICALS- OPTION YEAR
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2017-05-17+$43,875$643,593RADIOPHARMACEUTICALS- OPTION YEAR
Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2018-03-19+$11,710$655,303RADIOPHARMACEUTICALS- OPTION YEAR

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JV1AHJHGUGG3)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0392255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$357,066FY2026
36C25526N0245255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$1,172,834FY2026
36C24226N0463242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$624,017FY2026
36C24226N0388242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$830,796FY2026
36C24226D0040242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C25026P0310250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$347,000FY2026

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26113C0017_3600_-NONE-_-NONE- · retrieved 2026-09-26.